NCT01147900View on ClinicalTrials.gov

Evaluation of Boostrix™10 Years After Previous Booster Vaccination

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 15, 2010

Primary Completion Date

May 8, 2012

Study Completion Date

May 8, 2012

Conditions
Acellular PertussisTetanusDiphtheria
Interventions
BIOLOGICAL

Boostrix™

Intramuscular, single dose

BIOLOGICAL

Boostrix™-US formulation

Intramuscular, single dose

Trial Locations (3)

1200

GSK Investigational Site, Brussels

2610

GSK Investigational Site, Wilrijk

3000

GSK Investigational Site, Leuven

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01147900 - Evaluation of Boostrix™10 Years After Previous Booster Vaccination | Biotech Hunter | Biotech Hunter